LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.215
-0.025 (-2.02%)
May 6, 2025, 12:15 PM EDT - Market open
LAVA Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 35.02 | 44.23 | 100.33 | 90.87 | 15.82 | Upgrade
|
| Short-Term Investments | 41.56 | 51.34 | 32.54 | 42.33 | - | Upgrade
|
| Cash & Short-Term Investments | 76.58 | 95.57 | 132.87 | 133.2 | 15.82 | Upgrade
|
| Cash Growth | -19.88% | -28.07% | -0.25% | 742.10% | 115.56% | Upgrade
|
| Accounts Receivable | - | - | 3.25 | 0.36 | 1.14 | Upgrade
|
| Other Receivables | - | - | - | 0.37 | 0.34 | Upgrade
|
| Receivables | - | - | 3.25 | 0.73 | 1.48 | Upgrade
|
| Prepaid Expenses | 1.07 | 1.63 | 4.41 | 2.57 | 0.12 | Upgrade
|
| Other Current Assets | 1.65 | 1.7 | - | - | 0.81 | Upgrade
|
| Total Current Assets | 79.3 | 98.9 | 140.53 | 136.51 | 18.22 | Upgrade
|
| Property, Plant & Equipment | 1.44 | 2.46 | 2.08 | 1.95 | 1.5 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.32 | 0.81 | 0.8 | 0.77 | Upgrade
|
| Total Assets | 80.83 | 101.67 | 143.43 | 139.25 | 20.49 | Upgrade
|
| Accounts Payable | 2.72 | 4.45 | 3.97 | 2.55 | 0.93 | Upgrade
|
| Accrued Expenses | 9.13 | 4.29 | 7.83 | 1.57 | 1.27 | Upgrade
|
| Current Portion of Long-Term Debt | 4.89 | 5.28 | 4.64 | - | - | Upgrade
|
| Current Portion of Leases | 0.32 | 0.42 | 0.38 | 0.26 | 0.21 | Upgrade
|
| Current Unearned Revenue | - | - | - | 1.53 | 4.52 | Upgrade
|
| Other Current Liabilities | 0.95 | 0.46 | 5.14 | 5.34 | 0.41 | Upgrade
|
| Total Current Liabilities | 18.01 | 14.89 | 21.95 | 11.25 | 7.34 | Upgrade
|
| Long-Term Debt | - | - | - | 4.28 | 3.6 | Upgrade
|
| Long-Term Leases | 0.08 | 0.42 | 0.43 | 0.32 | 0.27 | Upgrade
|
| Long-Term Unearned Revenue | 35 | 35 | 35 | - | 1.66 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 5.03 | - | Upgrade
|
| Total Liabilities | 53.09 | 50.31 | 57.39 | 20.88 | 12.87 | Upgrade
|
| Common Stock | 3.72 | 3.72 | 3.72 | 3.65 | - | Upgrade
|
| Additional Paid-In Capital | 211.66 | 208.41 | 194.42 | 192.27 | 41.09 | Upgrade
|
| Retained Earnings | -174.97 | -149.86 | -108.07 | -76.16 | -33.39 | Upgrade
|
| Comprehensive Income & Other | -12.66 | -10.9 | -4.03 | -1.39 | -0.08 | Upgrade
|
| Shareholders' Equity | 27.75 | 51.36 | 86.04 | 118.37 | 7.62 | Upgrade
|
| Total Liabilities & Equity | 80.83 | 101.67 | 143.43 | 139.25 | 20.49 | Upgrade
|
| Total Debt | 5.28 | 6.11 | 5.45 | 4.87 | 4.08 | Upgrade
|
| Net Cash (Debt) | 71.3 | 89.46 | 127.42 | 128.34 | 11.74 | Upgrade
|
| Net Cash Growth | -20.30% | -29.79% | -0.72% | 993.54% | 110.59% | Upgrade
|
| Net Cash Per Share | 2.66 | 3.35 | 4.92 | 6.50 | 29.40 | Upgrade
|
| Filing Date Shares Outstanding | 26.31 | 26.29 | 26.29 | 25.78 | 0.4 | Upgrade
|
| Total Common Shares Outstanding | 26.31 | 26.29 | 26.29 | 25.78 | 0.4 | Upgrade
|
| Working Capital | 61.29 | 84 | 118.58 | 125.26 | 10.89 | Upgrade
|
| Book Value Per Share | 1.05 | 1.95 | 3.27 | 4.59 | 19.09 | Upgrade
|
| Tangible Book Value | 27.75 | 51.36 | 86.04 | 118.37 | 7.62 | Upgrade
|
| Tangible Book Value Per Share | 1.05 | 1.95 | 3.27 | 4.59 | 19.09 | Upgrade
|
| Buildings | - | - | 0.12 | 0.12 | 0.11 | Upgrade
|
| Machinery | 2.65 | 2.96 | 2.42 | 1.95 | 1.34 | Upgrade
|
| Leasehold Improvements | 0.36 | 0.38 | - | - | - | Upgrade
|
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.